Reality of obesity paradox: Results of percutaneous coronary intervention in Middle Eastern patients

The Journal of International Medical Research
Mohamad JarrahIssa M Hweidi

Abstract

Objective The aim of this study was to assess the baseline clinical characteristics, coronary angiographic features, and adverse cardiovascular events during hospitalization and at 1 year of follow-up in obese patients compared with overweight and normal/underweight patients. Methods A prospective, multicenter study of consecutive patients undergoing percutaneous coronary intervention was performed. Results Of 2425 enrolled patients, 699 (28.8%) were obese, 1178 (48.6%) were overweight, and 548 (22.6%) were normal/underweight. Obese patients were more likely to be female and to have a higher prevalence of diabetes, hypertension, hypercholesterolemia, or previous percutaneous coronary intervention. Acute coronary syndrome was the indication for percutaneous coronary intervention in 77.0% of obese, 76.4% of overweight, and 77.4% of normal/underweight patients. No significant differences in the prevalence of multi-vessel coronary artery disease or multi-vessel percutaneous coronary intervention were found among the three groups. Additionally, no significant differences were found in stent thrombosis, readmission bleeding rates, or cardiac mortality among the three groups during hospitalization, at 1 month, and at 1 year. Conclusio...Continue Reading

References

Apr 1, 1995·Annals of Internal Medicine·G A ColditzJ E Manson
Aug 31, 2001·Journal of the American College of Cardiology·T B HorwichJ H Tillisch
May 2, 2007·Circulation·Donald E CutlipUNKNOWN Academic Research Consortium
Nov 10, 2007·Seminars in Dialysis·Darren S Schmidt, Abdulla K Salahudeen
Jul 22, 2008·Chest·Wael GalalDon Poldermans
Aug 2, 2008·Clinics in Geriatric Medicine·John E Morley
Aug 18, 2009·The American Journal of Medicine·Carl J LavieHector O Ventura
Sep 8, 2009·European Heart Journal·Wolfram DoehnerStefan D Anker
Dec 4, 2010·Stroke; a Journal of Cerebral Circulation·Konstantinos VemmosMaria Alevizaki
Sep 29, 2011·International Journal of Obesity : Journal of the International Association for the Study of Obesity·N S HongD H Lee
Aug 9, 2012·JAMA : the Journal of the American Medical Association·Hermes Florez, Sumaya Castillo-Florez
Jan 3, 2013·JAMA : the Journal of the American Medical Association·Katherine M FlegalBarry I Graubard
Oct 1, 2013·Obesity·Deirdre K Tobias, Frank B Hu
Jan 17, 2014·The New England Journal of Medicine·Deirdre K TobiasFrank B Hu
Mar 25, 2014·Annals of Saudi Medicine·Abdulelah Fahad MobeirekMostafa Alshamiri
Oct 31, 2014·European Journal of Epidemiology·Jacek NiedzielaPiotr Rozentryt
Nov 8, 2014·Circulation·Mercedes R Carnethon
Jul 8, 2015·Circulation·Goutham RaoUNKNOWN American Heart Association Obesity Committee of the Council on Lifestyle and Cardiometabolic Health
Sep 5, 2015·International Journal of Obesity : Journal of the International Association for the Study of Obesity·L WangP Yin
Apr 22, 2017·Kidney Research and Clinical Practice·Jongha Park
Oct 17, 2017·Pragmatic and Observational Research·Efstratios VlarasHero Brokalaki

❮ Previous
Next ❯

Citations

Sep 19, 2020·International Journal of Obesity : Journal of the International Association for the Study of Obesity·Zuhur BalayahMohammad Zubaid

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass
underwent

Software Mentioned

SPSS Statistics
CRUSADE

Related Concepts

Related Feeds

Antipsychotic-Induced Weight Gain

Antipsychotic-induced weight gain (aiwg) is a common adverse effect of this treatment, particularly with second-generation antipsychotics, and it is a major health problem around the world. Here are the latest discoveries pertaining to AIWG.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.